Date | For | Estimate | Reported | Surprise | surprise % |
---|---|---|---|---|---|
2024-11-11 | 2024-09 | -0.05 | N/A | N/A | N/A |
2024-08-12 | 2024-06 | -0.05 | -0.05 | N/A | N/A |
2024-05-13 | 2024-03 | -0.07 | -0.05 | 0.02 | 28.57% |
2024-04-01 | 2023-12 | -0.05 | -0.06 | -0.01 | -20.00% |
2023-11-13 | 2023-09 | 0 | -0.05 | N/A | N/A |
2023-08-14 | 2023-06 | 0 | -0.06 | N/A | N/A |
Date | Firm | Action | From | To |
---|---|---|---|---|
2023-09-07 | Cantor Fitzgerald | Upgrade | Overweight | |
2020-09-16 | Ascendiant Capital | Upgrade | Buy | |
2019-12-17 | Maxim Group | Upgrade | Hold | Buy |
2018-01-25 | Maxim Group | Upgrade | Buy | |
2013-10-06 | Sidoti & Co. | Downgrade | Buy | Neutral |
2013-04-14 | Sidoti & Co. | Upgrade | Buy |
Date | Name | Relation | Quantity | Description |
---|---|---|---|---|
2016-03-08 | CHEN SHU-CHIH | Director and Beneficial Owner of more than 10% of a Class of Security | 0.00 | Purchase |
2013-05-14 | CROSS ALEXANDER DENNIS | Director | 0.00 | Purchase |
2024-04-09 | FINN JONATHAN F. | Director | 25.00K | Purchase |
2017-11-14 | GUSE KYLE | General Counsel | 10.00K | Purchase |
2016-03-08 | QUAY STEVEN C | Chief Executive Officer | 0.00 | Purchase |
2017-04-16 | REMMEL H LAWRENCE | Director | 3.13K | Purchase |
Report Date | Organization | Position | Value | Percentage |
---|---|---|---|---|
2023-06-29 | Vanguard Group Inc | 5.68M | 7.15M | 4.51% |
2023-06-29 | Blackrock Inc. | 2.90M | 3.65M | 2.30% |
2023-06-29 | Laurion Capital Management, LP | 2.23M | 2.80M | 1.77% |
2023-06-29 | Geode Capital Management, LLC | 1.11M | 1.40M | 0.88% |
2023-06-29 | Renaissance Technologies, LLC | 1.07M | 1.35M | 0.85% |
2023-06-29 | State Street Corporation | 436.27K | 549.70K | 0.35% |
Report Date | Organization | Position | Value | Percentage |
---|---|---|---|---|
2023-06-29 | Vanguard Total Stock Market Index Fund | 3.78M | 4.76M | 3.00% |
2023-06-29 | Vanguard Extended Market Index Fund | 1.66M | 2.10M | 1.32% |
2023-05-30 | Fidelity Extended Market Index Fund | 659.95K | 613.75K | 0.52% |
2023-05-30 | BlackRock Advantage Small Cap Core Fund | 340.50K | 316.67K | 0.27% |
2023-05-30 | Fidelity Total Market Index Fund | 182.91K | 170.11K | 0.15% |
2023-05-30 | Fidelity Series Total Market Index Fund | 142.17K | 132.22K | 0.11% |
Split | Date |
---|---|
1 : 12 | 2018-04-20 |
1 : 15 | 2016-08-26 |
-
FASTRACK FDA will send this past $10
-
Don’t get caught out of position trying to save a few bucks. You could end up chasing massive share price
-
You realize there will be nothing but positive news here..this thing could go parabolic,,,especially with any mention of FDA
-
Sell now before the anticlimactic panel discussion and buy back after when it dips to 3
-
As soon as he gives the news this will fly
-
About to be a FOMO run
-
This is going to dive..good buying op
-
FOMO will kick in 30 minutes prior to meeting. Will run back up
-
It's the sell off before the big conference...this will prob go negative by end of day
-
Can't wait to sell before the conference..you idiots that think this is an ATOS conference will see a sell off
-
Bio rad ticker BIO is going to be chair of the session dr quay is a part of...wonder why that stock is not running if there is "big news" coming from this session.
-
For those of you without medical background...this is a game changer in the fight against COVID. We herbalists have know for moths that COVID replicates via the ACE 2 receptors in the nose. The most effective way to reduce viral load and allow the body to fight the infection is to attack it in the nostrils. This is easy and non invasive.I personally swab daily with an herbal antiviral, and use the same formula in a nebulizer to treat my Covid patients, all of whom become symptom free within 3 to 5 days, and Covid negative in 8 to 10.
They also regain their sense of smell within about 2 days of treatment.
Between this and the Covid breath detector developed by AstroTech for use in airports and other public places, we have the tools in place to defeat this virus.
Very excited ! -
Roaches trying so hard. But world knows where their place is.. Its a sewage. Soon they going there. Lol
-
The conference is not as big as you think.
-
You can always predict when stocks start on a downward path, cause these tits all start crying about people selling.
-
When the crybabies show up whining about people selling, that’s when you know the true RH noobs have arrived. Mfers have no clue how the process actually works.
-
STOP CRYING ABOIT PEOPLE SELLING!!!!!!!
-
Would you damn crybabies stop worrying about other people selling? You sound like a bunch of damn RH noobs.
-
Expect a sell off after meeting. Most people here don't understand what a discussion panel is and don't understand that this meeting will not focus on Atos at all. People are dumb and don't do due diligence.
-
Can't wait for the "conference" to buy the dip...people are going to be upset and sell when they don't talk about Atos at all during it. Dr quay over under is 5 min of air time to discuss his opinion on the market is not going to help the stock's price. I expect a lot of dips before you see 5 bucks.
-
Atos: contract to reinforce a supercomputer in Sweden
news.google.com • -
Atossa Therapeutics Granted Additional Patent Protection for Endoxifen
globenewswire.com • -
3 Dirt-Cheap Drug Developers With Blockbuster Potential
investorplace.com • -
3 Penny Stock Moonshots with 300%+ Upside Potential by 2025
investorplace.com • -
Atossa Therapeutics names Heather Rees as CFO
proactiveinvestors.com • -
Atossa Therapeutics Appoints Heather Rees as Chief Financial Officer
globenewswire.com • -
Atossa Set to Join Russell 3000® Index Effective June 28, 2024
globenewswire.com • -
Meme Mania Meets Medicine: 3 Biotech Stocks Primed to Soar
investorplace.com • -
Atossa to Present at the Sidoti Small-Cap Investor Conference
globenewswire.com •